Breaking news

The Worst Performing Stocks In The S&P 500 So Far, From Boeing To Intel

KEY FACTS

  • Drugstore chain Walgreens was the worst-performing company in the S&P 500, a benchmark that tracks the share prices of the 500 largest U.S. companies. In the first six months of the year, Walgreens’ stock price halved to its lowest level since the mid-1990s, coinciding with the company’s plans to close up to a quarter of its locations as analysts predicted Walgreens’ worst annual profit since 2013.
  • Lululemon, the high-end athletic apparel company, is the second-worst performing stock YTD on the S&P, as analysts expect the retailer to report its worst annual revenue growth since Lululemon went public in 2007 ., other than the fiscal year ending in January. 2021.
  • Intel, the S&P’s third-worst performer, was perhaps the most surprising loser, given that rival Nvidia and other silicon chip companies have been among the best-returning investments this year amid the AI ​​frenzy. Intel’s stock has largely been a victim  of the company’s prolonged decline in business competition has intensified, with some analysts going so far as to declare Intel a “broken company.” Intel’s first-quarter earnings of $1.8 billion before interest, taxes, depreciation and amortization were the second worst first quarter since at least 2000, an improvement over last year’s EBITDA of $962 million. , but represents an 82% drop from $10.3 billion in the first quarter of 2020. For reference, Nvidia’s net profit for the spring quarter rose from $1.1 billion to $17.3 billion from 2020 to 2024
  • Boeing, the 10th largest returner in the S&P, certainly wasn’t shockingly low. Its stock market woes came as the airline faced what has become a public relations nightmare after several of its commercial jets broke down. That led to a Justice Department investigation, a congressional hearing focused on its problems, and this spring its worst quarterly earnings in eight quarters. All of this has disappointed investors, and Boeing is on a five-year streak of negative earnings.
  • For shares of entertainment giants Warner Bros. Discovery and Paramount Global, the fifth and twelfth biggest losers in the S&P, respectively, had a far from picture-perfect 2024 as both HBO parent WBD and CBS parent Paramount struggled with shaky balance sheets. WBD and Paramount reported net losses of $966 million and $563 million, respectively, in the first quarter — far worse than Wall Street’s Hollywood darling Netflix’s net income of $2.2 billion.
  • Such negative headlines weighed on entertainment conglomerates, and the expected loss of WBD’s NBA rights led to a 10% one-day selloff on April 30, while Paramount shares tumbled 8% on June 11 after the company ended talks to sell Skydance Media, managed by the son of billionaire Larry Ellison – David Ellison.

Cyprus: A Global Leader in Longevity and Healthcare Efficiency

In an eye-opening study conducted by renowned universities Brown and Harvard, Cyprus emerges as a global leader in longevity while maintaining low healthcare expenditures. The study, led by Cypriot professor Irini Papanikola, uncovers insightful data on Cyprus’s healthcare efficiency.

Key Findings

Published in the prestigious Journal of the American Medical Association Internal Medicine, the study highlights that Cyprus boasts some of the lowest mortality rates among high-income countries while ensuring affordable healthcare. This research has drawn significant attention, featured in media outlets across America and Europe.

Understanding Avoidable Mortality

The study examines avoidable mortality (deaths preventable through timely healthcare) across U.S. states and 40 high-income countries from 2009 to 2021. Remarkably, Cyprus presents some of the lowest avoidable mortality rates, showcasing the efficiency of its healthcare system even amid global challenges such as the COVID-19 pandemic.

Trends and Challenges

From 2009 to 2019, most high-income countries saw a decrease in avoidable mortality; however, this trend reversed for many, including Cyprus, during the pandemic years. The findings emphasize the critical role of robust public health systems in sustaining positive health outcomes.

The Path Forward

Despite the pandemic, Cyprus’s overall performance remains commendable. To achieve success, experts suggest addressing broader health determinants, focusing on preventive measures like road safety and mental health support through collaborative efforts.

Conclusion

Overall, Cyprus stands out as a beacon of healthcare efficiency, managing to reduce avoidable mortality with relatively low costs. This achievement underscores the country’s adeptness in providing high-quality healthcare, although continued research into population needs is vital for ongoing improvements.

The Future Forbes Realty Global Properties

Become a Speaker

Become a Speaker

Become a Partner

Subscribe for our weekly newsletter